Global  

Novartis, Merck and Allergan join those raising U.S. drug prices for 2020

Reuters Friday, 3 January 2020
Novartis AG, Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, bringing the tally to 445 drugs that will cost more in 2020, according to data analyzed by healthcare research firm 3 Axis Advisors.
0
shares
ShareTweetSavePostSend
 

You Might Like


Tweets about this